Terms ending in 2027
Musc Foundation for Research Development
Every in-force patent on Musc Foundation for Research Development's record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,007,804 | Complement Receptor 2 Targeted Complement Modulators In force · High confidence | The Regents of the University of Colorado, a Body Corporate | In force | High confidence | |
| US 7,759,304 | Targeting Complement Factor H for Treatment of Diseases In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 9,212,212 | Targeting Complement Factor H for Treatment of Diseases In force · Medium confidence | Musc Foundation for Research Development | In force | Medium confidence | |
| US 8,735,365 | Targeting PAX2 for the Induction of DEFB1-MEDIATED Tumor Immunity and Cancer Therapy In force · Medium confidence | Musc Foundation for Research Development | In force | Medium confidence | |
| US 7,964,577 | Targeting PAX2 for the Induction of DEFB1-MEDIATED Tumor Immunity and Cancer Therapy In force · High confidence | Phigenix, Inc. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Musc Foundation for Research Development.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.